Business · 1 sources covering this

Cohance Lifesciences Stock Jumps Over 2% Despite Poor Q1 Earnings; Here's Why

Shares of Cohance Lifesciences advanced in trade even after weak Q1 results, with the market taking comfort from the absence of data integrity observations in the USFDA inspection.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·2h ago
Cohance Lifesciences Stock Jumps Over 2% Despite Poor Q1 Earnings; Here's Why
Shares of Cohance Lifesciences advanced in trade even after weak Q1 results, with the market taking comfort from the absence of data integrity observations in the USFDA inspection.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/b156978707e349cf7b74f507548da1d32ed5ed50"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Cohance Lifesciences Stock Jumps Over 2% Despite Poor Q1 Earnings; Here's Why"></iframe>

Cohance Lifesciences Stock Jumps Over 2% Despite Poor Q1 Earnings; Here's Why

How 1 sources are covering this

Cohance Lifesciences Stock Jumps Over 2% Despite Poor Q1 Earnings; Here's Why

More from Business

Quote of the Day by Ruskin Bond: ‘Happiness is a mysterious thing, to be found somewhere between…’

Trump administration refunds $100 billion in tariffs struck down by US Supreme Court

Trump dismisses reports of ammo shortage

Google's $15 bn India project battles wildlife woes

Reader

Trust & legal

Across the network